U.S. market Closed. Opens in 1 day 2 hours 25 minutes

BIO-B | Bio-Rad Laboratories, Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for BIO-B we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is unacceptably poor, Growth is good and Health is very strong.

Valuation (53%)

Company Industry
P/E Ratio (TTM) -11.75 35.44
PEG Ratio (TTM) -0.28 -2.74
P/S Ratio (TTM) 3.56 6.39
P/B Ratio (TTM) 1.22 5.95
P/FCF Ratio (TTM) 41.14 45.33
Price to 5YR AVG Earnings Ratio 8.76 62.55
Price to 5YR AVG FCF Ratio 27.18 34.45

Profitability (5%)

Company Industry
ROA (TTM) -7.34% 5.33%
ROE (TTM) -9.72% 26.24%
Net Profit Margin (TTM) -30.18% 0.94%
ROIC 5YR AVG 4.11% 4.32%

Growth (67%)

4QTR AVG 3YR AVG 5YR AVG
EPS -73.07% 171.84% 82.44%
Revenue 0.93% 8.62% 3.42%
Net Income -73.75% 171.86% 82.55%
Cash Flow 19.25% 33.38% 24.52%

Health (75%)

Company Industry
Current Ratio (TTM) 6.14 2.59
Quick Ratio (TTM) 4.52 1.96
D/E Ratio (TTM) 0.16 -0.04
Interest Coverage (TTM) 6.41 13.08
Piotroski F-Score 6 6
Altman Z-Score 3.06 7.11
LTL to 5YR AVG FCF 4.06 3.62
Shares Outstanding Growth 5YR AVG -0.42% 2.25%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙